Workflow
哈药股份(600664) - 2024 Q2 - 季度业绩预告
HPGCHPGC(SH:600664)2024-07-09 09:07

Financial Performance Expectations - The company expects a net profit attributable to shareholders for the first half of 2024 to be between 312.3 million and 374.75 million yuan, representing a year-on-year increase of 71% to 105%[10] - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between 283.8 million and 340.56 million yuan, with a year-on-year increase of 84% to 120%[11] - The net profit for the same period last year was 182.71 million yuan, and the net profit after deducting non-recurring gains and losses was 154.60 million yuan[5] Factors Influencing Profit Increase - The increase in net profit is primarily due to improved performance in the pharmaceutical industrial sector, driven by a shift from a distribution model to a terminal promotion model[6] - The company has optimized its marketing strategies and resource allocation, enhancing product competitiveness and increasing gross margins[6] - The company has made adjustments to its sales organization structure to better align with market dynamics[6] Earnings Forecast Validity - There are no significant uncertainties affecting the accuracy of this earnings forecast[7] - The earnings forecast has not been audited by registered accountants[4] - The expected earnings figures are preliminary and subject to confirmation in the official half-year report[4] - The company assures that the announcement contains no false records or misleading statements[10]